BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heathcote J. Autoimmune cholangitis. Gut. 1997;40:440-442. [PMID: 9176067 DOI: 10.1136/gut.40.4.440] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Gisbert JP, Jones EA, Pajares JM, Moreno-otero R. Is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?: REVIEW: TREATMENT OF AUTOIMMUNE CHOLANGITIS. Alimentary Pharmacology & Therapeutics 2003;17:17-27. [DOI: 10.1046/j.1365-2036.2003.01381.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nguyen-khac E, Kairis L, Gournay N, Bonniere M, Thevenot T, Mathurin P, Hachulla E, Paris J, Dupas J. « Overlap syndrome » ou syndrome de chevauchement entre cirrhose biliaire primitive et hépatite auto-immune. Gastroentérologie Clinique et Biologique 2004;28:1107-16. [DOI: 10.1016/s0399-8320(04)95189-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Chatzicostas C, Roussomoustakaki M, Drygiannakis D, Niniraki M, Tzardi M, Koulentaki M, Dimoulios P, Mouzas I, Kouroumalis E. Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete. BMC Gastroenterol 2002;2:5. [PMID: 11914139 DOI: 10.1186/1471-230x-2-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
4 Chazouillères O. The variant forms of cholestatic diseases involving small bile ducts in adults. Journal of Hepatology 2000;32:16-8. [DOI: 10.1016/s0168-8278(00)80437-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Invernizzi P, Battezzati PM, Crosignani A, Zermiani P, Bignotto M, Del Papa N, Zuin M, Podda M. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol. 1998;114:448-454. [PMID: 9844056 DOI: 10.1046/j.1365-2249.1998.00735.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
6 O'Donohue J, Wong T, Portmann B, Williams R. Immunohis-tochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur J Gastroenterol Hepatol. 2002;14:1143-1150. [PMID: 12362106 DOI: 10.1097/00042737-200210000-00016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
7 Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:323-331; viii-ix. [PMID: 18456183 DOI: 10.1016/j.cld.2008.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
8 Neuberger J. Antibodies and primary biliary cirrhosis – piecing together the jigsaw. Journal of Hepatology 2002;36:126-9. [DOI: 10.1016/s0168-8278(01)00303-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Heathcote J. Variant syndromes of autoimmune hepatitis. Clinics in Liver Disease 2002;6:669-84. [DOI: 10.1016/s1089-3261(02)00031-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
10 Agarwal K, Jones DE, Watt FE, Burt AD, Floreani A, Bassendine MF. Familial primary biliary cirrhosis and autoimmune cholangitis. Dig Liver Dis. 2002;34:50-52. [PMID: 11930900 DOI: 10.1016/S1590-8658(02)80059-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Jiang XH, Zhong RQ, Fan XY, Hu Y, An F, Sun JW, Kong XT. Characterization of M2 antibodies in asymptomatic Chinese population. World J Gastroenterol 2003; 9(9): 2128-2131 [PMID: 12970922 DOI: 10.3748/wjg.v9.i9.2128] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
12 Castro F, Narváez F, Vilaseca J. Colangitis autoinmune con buena respuesta a corticoides. Gastroenterología y Hepatología 2001;24:462. [DOI: 10.1016/s0210-5705(01)79005-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
13 Beuers U. Hepatic overlap syndromes. J Hepatol 2005;42 Suppl:S93-9. [PMID: 15777577 DOI: 10.1016/j.jhep.2004.11.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol. 2000;53:813-821. [PMID: 11127262 DOI: 10.1136/jcp.53.11.813] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
15 Sharma B, Raina S, Sharma R. Autoimmune cholangitis: a variant syndrome of autoimmune hepatitis. Case Reports Hepatol 2014;2014:501530. [PMID: 25374727 DOI: 10.1155/2014/501530] [Reference Citation Analysis]
16 Neuberger J, Thomson R. PBC and AMA--what is the connection? Hepatology. 1999;29:271-276. [PMID: 9862877 DOI: 10.1002/hep.510290126] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
17 Gogos CA, Nikolopoulou V, Zolota V, Siampi V, Vagenakis A. Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. Journal of Hepatology 1999;30:321-4. [DOI: 10.1016/s0168-8278(99)80079-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nakanuma Y, Harada K. Primary cholangiohepatitis as an alternative name for primary biliary cirrhosis. Pathol Int 2003;53:412-4. [DOI: 10.1046/j.1440-1827.2003.01490.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
19 Volta U, Rodrigo L, Granito A, Petrolini N, Muratori P, Muratori L, Linares A, Veronesi L, Fuentes D, Zauli D. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol. 2002;97:2609-2613. [PMID: 12385447 DOI: 10.1111/j.1572-0241.2002.06031.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
20 Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002;97:2402-2407. [PMID: 12358264 DOI: 10.1111/j.1572-0241.2002.06019.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 145] [Article Influence: 8.2] [Reference Citation Analysis]
21 Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003;98:431-437. [PMID: 12591064 DOI: 10.1111/j.1572-0241.2003.07257.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 129] [Article Influence: 7.6] [Reference Citation Analysis]
22 Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E. Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma. Liver. 1999;19:122-128. [PMID: 10220742 DOI: 10.1111/j.1478-3231.1999.tb00021.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
23 Bianchi FB, Muratori P, Muratori L. New autoantibodies and autoantigens in autoimmune hepatitis. Clinics in Liver Disease 2002;6:785-97. [DOI: 10.1016/s1089-3261(02)00027-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
24 Heyman SN, Spectre G, Aamar S, Rubinger D, Pappo O, Ackerman Z. Autoimmune cholangiopathy associated with systemic lupus erythematosus: Autoimmune cholangiopathy and SLE. Liver 2002;22:102-6. [DOI: 10.1034/j.1600-0676.2002.01533.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
25 Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Guidi M, Ferri S, DE Molo C, Lenzi M. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24:1575-1583. [PMID: 17206945 DOI: 10.1111/j.1365-2036.2006.03172.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
26 Chazouillères O. « Overlap syndrome » cirrhose biliaire primitive — hépatite auto-immune : le temps de la maturité ? Gastroentérologie Clinique et Biologique 2007;31:7-9. [DOI: 10.1016/s0399-8320(07)89321-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
27 Csepregi A, Szodoray P, Zeher M. Do Autoantibodies Predict Autoimmune Liver Disease in Primary Sjögren's Syndrome? Data of 180 Patients upon a 5 Year Follow-Up: Clinical Value of Autoantibodies in Primary SS. Scandinavian Journal of Immunology 2002;56:623-9. [DOI: 10.1046/j.1365-3083.2002.01165.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
28 Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT. Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2003; 9(6): 1352-1355 [PMID: 12800255 DOI: 10.3748/wjg.v9.i6.1352] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
29 Brahim I, Brahim I, Hazime R, Admou B. [Autoimmune hepatitis: Immunological diagnosis]. Presse Med 2017;46:1008-19. [PMID: 28919271 DOI: 10.1016/j.lpm.2017.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008; 14(21): 3368-3373 [PMID: 18528934 DOI: 10.3748/wjg.14.3368] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
31 Li C, Xu P, Wang C, Zou G. Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease. Clinica Chimica Acta 2006;365:135-42. [DOI: 10.1016/j.cca.2005.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
32 Juliusson G, Imam M, Björnsson ES, Talwalkar JA, Lindor KD. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis. Scand J Gastroenterol. 2016;51:745-752. [PMID: 26776319 DOI: 10.3109/00365521.2015.1132337] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, Ohba K, Isomoto H, Murase K, Murata I. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis. J Gastroenterol Hepatol. 2001;16:239-243. [PMID: 11207911 DOI: 10.1046/j.1440-1746.2001.02377.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
34 Neuberger J. Primary biliary cirrhosis. Lancet. 1997;350:875-879. [PMID: 9310614 DOI: 10.1016/s0140-6736(97)05419-6] [Cited by in Crossref: 135] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
35 Ozaslan E, Efe C, Gokbulut Ozaslan N. The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis. Clin Res Hepatol Gastroenterol 2016;40:553-61. [PMID: 27567165 DOI: 10.1016/j.clinre.2016.06.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
36 Sherlock S. OVERVIEW OF CHRONIC CHOLESTATIC CONDITIONS IN ADULTS. Clinics in Liver Disease 1998;2:217-33. [DOI: 10.1016/s1089-3261(05)70004-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Sedlack RE, Smyrk TC, Czaja AJ, Talwalkar JA. Celiac disease-associated autoimmune cholangitis. Am J Gastroenterol. 2002;97:3196-3198. [PMID: 12492211 DOI: 10.1111/j.1572-0241.2002.07131.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
38 Fritzler MJ, Manns MP. Anti-mitochondrial autoantibodies. Clinical and Applied Immunology Reviews 2002;3:87-113. [DOI: 10.1016/s1529-1049(02)00058-2] [Cited by in Crossref: 18] [Article Influence: 0.9] [Reference Citation Analysis]
39 Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis. 2004;8:177-194. [PMID: 15062200 DOI: 10.1016/s1089-3261(03)00132-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012;16:199-229. [PMID: 22541695 DOI: 10.1016/j.cld.2012.03.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]